These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4912804)

  • 21. Immunosuppression and clinical organ transplantation.
    Calne RY
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):49-51. PubMed ID: 4612904
    [No Abstract]   [Full Text] [Related]  

  • 22. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined immunosuppression for canine renal allograft prolongation: antilymphocyte serum plus prednisolone or azathioprine.
    Weil R; Simmons RL
    Ann Surg; 1968 Feb; 167(2):239-45. PubMed ID: 4866845
    [No Abstract]   [Full Text] [Related]  

  • 24. Preparation and clinical use of antilymphocyte globulin.
    Stevens LE; Freeman JS; Keutel H; Reemtsma K
    Am J Surg; 1968 Nov; 116(5):795-9. PubMed ID: 4176515
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function.
    Castelao AM; Griñó JM; Sabaté I; Gilvernet S; Andres E; Sabater R; Alsina J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497
    [No Abstract]   [Full Text] [Related]  

  • 26. Kidney transplantation for patients with diabetes mellitus.
    Najarian JS; Henriksen AI; Simmons RL; Kjellstrand CM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):121-7. PubMed ID: 4612898
    [No Abstract]   [Full Text] [Related]  

  • 27. [The role of histocompatibility and antilymphocyte globulins in the early development of human renal homotransplantation].
    Van Ypersele de Strihou ; Alexandre GP; Coche E; Sokal G
    J Urol Nephrol (Paris); 1969 Sep; 75(9):608-15. PubMed ID: 4103961
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolonged renal allograft survival associated with antigen pretreatment.
    Wilson RE; Rippen A; Hayes CR; Dagher RK; Busch GJ
    Transplant Proc; 1969 Mar; 1(1):290-2. PubMed ID: 4944229
    [No Abstract]   [Full Text] [Related]  

  • 29. [Renal homotransplantation in men. Results achieved in 37 patients 26 of whom had received antilymphocyte globulins].
    Küss R; Legrain M; Le Gall JR; Guédon J; Poisson J
    J Urol Nephrol (Paris); 1969 Sep; 75(9):594-600. PubMed ID: 4103960
    [No Abstract]   [Full Text] [Related]  

  • 30. Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin.
    Gruber SA; Pescovitz M; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Elick B; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1815-6. PubMed ID: 3079041
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal transplantation under cyclophosphamide.
    Starzl TE; Putnam CW; Halgrimson CG; Groth CG; Booth AS; Penn I
    Transplant Proc; 1972 Dec; 4(4):461-4. PubMed ID: 4566786
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclophosphamide for clinical renal and hepatic transplantation.
    Starzl TE; Groth CG; Putnam CW; Corman J; Halgrimson CG; Penn I; Husberg B; Gustafsson A; Cascardo S; Geis P; Iwatsuki S
    Transplant Proc; 1973 Mar; 5(1):511-6. PubMed ID: 4572111
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of immunosuppressive treatment and leukocyte antigen matching on kidney allografts in Rhesus monkeys.
    Dicke HW; Marquet RL; Heystek GA; Balner H
    Transplant Proc; 1971 Mar; 3(1):484-7. PubMed ID: 4106328
    [No Abstract]   [Full Text] [Related]  

  • 34. Editorial: Antilymphocyte globulin.
    Lancet; 1973 Oct; 2(7833):834. PubMed ID: 4126627
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical renal transplantation.
    Kountz SL
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):99-105. PubMed ID: 4612909
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolongation of canine renal homograft survival by post-transplantation treatment with antithymocyte serum.
    Hinchey EJ; Bliss JQ
    Ann Surg; 1970 Apr; 171(4):543-52. PubMed ID: 4392297
    [No Abstract]   [Full Text] [Related]  

  • 37. Discrepancy between PHA responsiveness and quantitative estimates of T-cell numbers in human peripheral blood during chronic renal failure and immunosuppression after transplantation.
    Lopez C; Simmons RL; Touraine JL; Park BH; Kiszkiss DF; Najarian JS; Good RA
    Clin Immunol Immunopathol; 1975 May; 4(1):135-42. PubMed ID: 1092496
    [No Abstract]   [Full Text] [Related]  

  • 38. Homograft survival and serum-blocking factors.
    Quadracci LJ; Pierce GE; Striker GE; Tremann JA; Marchioro TL
    Transplant Proc; 1973 Mar; 5(1):649-53. PubMed ID: 4572123
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical use of antilymphoblast serum.
    Najarian JS; Merkel FK; Moore GE; Good RA; Aust JC
    Transplant Proc; 1969 Mar; 1(1):460-2. PubMed ID: 5002662
    [No Abstract]   [Full Text] [Related]  

  • 40. The mixed leukocyte response in human renal transplantation.
    Shons AR; Etheredge EE; Schmidtke JR; Najarian JS
    Transplant Proc; 1973 Mar; 5(1):337-42. PubMed ID: 4266657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.